US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...

Fever was shortened by 2 day in kids with upper respiratory tract infections who received a probiotic mixture compared with ...

ADMA continues to maintain momentum in 2025 after its stupendous performance in 2024. Strong demand for Asceniv should fuel growth.